Cullinan Therapeutics Inc
(CGEM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,575 | -155,101 | 109,195 | -67,485 | -59,458 |
| Depreciation Amortization | 306 | 310 | 93 | 53 | 62 |
| Accounts payable and accrued liabilities | -812 | -167 | -509 | -4,835 | 5,581 |
| Other Working Capital | -389 | -339 | 11,176 | -3,541 | 6,851 |
| Other Operating Activity | 23,167 | 21,022 | -246,619 | 32,375 | 17,192 |
| Operating Cash Flow | $-145,303 | $-134,275 | $-126,664 | $-43,433 | $-29,772 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -208 | -1,042 | N/A | -10 |
| Net Acquisitions | N/A | N/A | 275,000 | N/A | 1,450 |
| Purchase Of Investment | -721,131 | -373,383 | -377,916 | -525,813 | -69,763 |
| Sale Of Investment | 584,817 | 409,397 | 352,933 | 192,038 | 62,903 |
| Investing Cash Flow | $-136,314 | $35,806 | $248,975 | $-333,775 | $-5,420 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,825 | 2,375 | N/A | N/A |
| Common Stock Issued | 270,636 | 38,926 | 6,020 | 270,549 | 145,506 |
| Other Financing Activity | -4,448 | 0 | -34,328 | -1,765 | -5,366 |
| Financing Cash Flow | $266,188 | $40,751 | $-25,933 | $268,784 | $140,140 |
| Beginning Cash Position | 98,434 | 156,152 | 59,774 | 168,198 | 63,250 |
| End Cash Position | 83,005 | 98,434 | 156,152 | 59,774 | 168,198 |
| Net Cash Flow | $-15,429 | $-57,718 | $96,378 | $-108,424 | $104,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | -145,303 | -134,275 | -126,664 | -43,433 | -29,772 |
| Capital Expenditure | N/A | -208 | -1,133 | 0 | -10 |
| Free Cash Flow | -145,303 | -134,483 | -127,797 | -43,433 | -29,782 |